Translational Lung Cancer Research

Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central, Scopus and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer and related thoracic diseases. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.

转化性肺癌研究(TLCR, Transl肺癌研究，ISSN 2218-6751;isn 2226-4477)是一份国际、同行评议、开放获取的期刊，成立于2012年3月。TLCR由科学引文索引扩展(SCIE)、PubMed/PubMed中心、Scopus和化学文摘服务(CAS)数据库索引。自2013年2月起，每季度出版一期，每月出版一期。它提供实用的最新信息，预防，早期发现，诊断和治疗肺癌和相关的胸部疾病。其感兴趣的具体领域包括但不限于，多模式治疗，标记物，成像，肿瘤生物学，病理学，化学预防，以及与肺癌和相关胸部疾病相关的技术进步。